sar-113945
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2010 (NCT01113333)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3544945 ↗
Also known as
- sar113945
- sar-113945
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01598415 | Phase 2 | Apr 1, 2012 | Sanofi |
| NCT01511549 | Phase 1 | Jan 1, 2012 | Sanofi |
| NCT01463488 | Phase 1 | Nov 1, 2011 | Sanofi |
| NCT01113333 | Phase 1 | Apr 1, 2010 | Sanofi |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sanofi | For profit | 4 | 4 | 2 | 2010 |
1 organizations
Page 1 / 1